Literature DB >> 1395317

Pseudarthrosis of the spine.

J C Steinmann1, H N Herkowitz.   

Abstract

Pseudarthrosis remains the leading cause of failed spinal fusions. The common causes of this complication are inadequate surgical technique, excessive stresses across the fusion site, insufficient internal or external stabilization, and unrecognized metabolic abnormalities. Many radiologic techniques have been used to diagnose pseudarthrosis in the spine. Nonetheless, the diagnosis of a nonunion as well as the ability to correlate the nonunion with the patient's clinical symptoms remains a challenge. In treating a symptomatic pseudarthrosis, the surgeon should first attempt to identify those factors that contributed to the development of a nonunion. The approach can then either be exploration of the fusion mass with regrafting of the pseudarthrosis or extending a fusion to locations within the abnormal segment of spinal motion.

Entities:  

Mesh:

Year:  1992        PMID: 1395317

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  38 in total

1.  Bone morphogenic proteins: applications in spinal surgery.

Authors:  Gerard K Jeong; Harvinder S Sandhu; James Farmer
Journal:  HSS J       Date:  2005-09

2.  Efficacy of platelet-rich plasma in posterior lumbar interbody fusion: systematic review and meta-analysis.

Authors:  Saran Pairuchvej; Janisa Andrea Muljadi; Alisara Arirachakaran; Jatupon Kongtharvonskul
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-12-20

3.  The relationship between serum vitamin D levels and spinal fusion success: a quantitative analysis.

Authors:  Melodie F Metzger; Linda E A Kanim; Li Zhao; Samuel T Robinson; Rick B Delamarter
Journal:  Spine (Phila Pa 1976)       Date:  2015-04-15       Impact factor: 3.468

4.  Efficacy of interspinous process lumbar fusion with recombinant human bone morphogenetic protein-2 delivered with a synthetic polymer and β-tricalcium phosphate in a rabbit model.

Authors:  Tomiya Matsumoto; Hiromitsu Toyoda; Sho Dohzono; Hiroyuki Yasuda; Shigeyuki Wakitani; Hiroaki Nakamura; Kunio Takaoka
Journal:  Eur Spine J       Date:  2011-12-28       Impact factor: 3.134

5.  Can povidone-iodine solution be used safely in a spinal surgery?

Authors:  Fang-Yeng Chang; Ming-Chau Chang; Shih-Tien Wang; Wing-Kwang Yu; Chien-Lin Liu; Tain-Hsiung Chen
Journal:  Eur Spine J       Date:  2005-08-20       Impact factor: 3.134

6.  Ex vivo transfer of the Hoxc-8-interacting domain of Smad1 by a tropism-modified adenoviral vector results in efficient bone formation in a rabbit model of spinal fusion.

Authors:  Joanne T Douglas; Angel A Rivera; Gray R Lyons; Patricia F Lott; Dezhi Wang; Majd Zayzafoon; Gene P Siegal; Xu Cao; Steven M Theiss
Journal:  J Spinal Disord Tech       Date:  2010-02

7.  Experimental posterolateral spinal fusion with beta tricalcium phosphate ceramic and bone marrow aspirate composite graft.

Authors:  Ankit Gupta; Vijendra Chauhan; Neena Chauhan; Sansar Sharma; Rajesh Maheshwari; Atul Agarwal
Journal:  Indian J Orthop       Date:  2010-10       Impact factor: 1.251

8.  Clinical and radiographic outcomes of posterolateral lumbar spine fusion in humans using recombinant human bone morphogenetic protein-2: an average five-year follow-up study.

Authors:  Yoshito Katayama; Yukihiro Matsuyama; Hisatake Yoshihara; Yoshihito Sakai; Hiroshi Nakamura; Shiro Imagama; Zenya Ito; Norimitsu Wakao; Mitsuhiro Kamiya; Yasutsugu Yukawa; Tokumi Kanemura; Koji Sato; Hisashi Iwata; Naoki Ishiguro
Journal:  Int Orthop       Date:  2008-06-26       Impact factor: 3.075

9.  The effect of risedronate on posterior lateral spinal fusion in a rat model.

Authors:  Ali Riza Gezici; Rüçhan Ergün; Kamil Gürel; Fahri Yilmaz; Onder Okay; Omer Bozdoğan
Journal:  J Korean Neurosurg Soc       Date:  2009-07-31

10.  The effect of noggin interference in a rabbit posterolateral spinal fusion model.

Authors:  E Klineberg; D R Haudenschild; K D Snow; S Garitty; B A Christiansen; C Acharya; S Maitra; M C Gupta
Journal:  Eur Spine J       Date:  2014-04-17       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.